Skip to main content

UBS Group AG

Position in NNVC — Nanoviricides, Inc.

CIK 1610520 ZURICH, V8

Position in NNVC

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$194,155
+$157,413 QoQ
Shares Held
213,359
+556.2% QoQ
Ownership
0.986%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NNVC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. NNVC ranks #334 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NNVC

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $194,155 213,359
2025-12-31 $36,742 32,516
2025-09-30 $38,221 26,728
2025-06-30 $164,033 117,168
2025-03-31 $6,254 5,346
2024-12-31 $6,864 4,800
2024-09-30 $4,030 2,687
2024-03-31 $489 422
2023-12-31 $969 950
2023-09-30 $781 583
2022-12-31 $8,220 7,406
2022-09-30 $10,380 6,000
2022-06-30 $21,125 11,237
2022-03-31 $36,466 17,448
2021-12-31 $30,258 8,134
2021-09-30 $32,725 7,053
2021-06-30 $47,179 10,168
2021-03-31 $23,883 5,060
2020-12-31 $11,652 4,060
2020-09-30 $230 60
2020-06-30 $725 97
2020-03-31 $27,603 4,809